NCT00174486View on ClinicalTrials.gov

Assessment Of Duration Of Action, Safety & Toleration Of UK369,003 and Cialis In Patients With Erectile Dysfunction

PHASE2CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

February 28, 2005

Study Completion Date

June 30, 2005

Conditions
Impotence
Interventions
DRUG

UK0369,003

DRUG

Cialis (Tadalafil)

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00174486 - Assessment Of Duration Of Action, Safety & Toleration Of UK369,003 and Cialis In Patients With Erectile Dysfunction | Biotech Hunter | Biotech Hunter